ARCHIVES

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

This article is from The Cancer Letter archive.

Vol. 25 No. 4 | April 26, 2002

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Issues: Maryland Law Mandates Insurance Coverage Of Patient Care Costs In Clinical Trials

July 3, 1998

L.I. Center At Stony Brook’s Goal Is Comprehensive Status.

October 27, 2000

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

NCI-Approved CTEP Trials For the Month of December

December 28, 2012

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009

ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated

March 12, 1999